Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics Corp. announced that the FDA has cleared its next-generation troponin T assay for use in ...

US physicians who’ve been waiting to get their hands on high-sensitivity troponin tests don’t have to wait any longer. Last week, the US Food and Drug Administration (FDA) gave 510(k) clearance to the ...

Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute ...

A modified algorithm using a high-sensitivity cardiac troponin T (hs-cTnT) assay safely and rapidly ruled out more patients with myocardial infarction in one US emergency department, with more than ...

Cardiac troponin T is a protein biomarker detectable with a blood test, and it is the preferred biomarker for determining cardiovascular risk. In a new study published in JAMA Cardiology, researchers ...

The current lower limit for detection of plasma troponin T in most commercially available tests is approximately 0.01 μg/l, and levels higher than this value are associated with increased mortality.

Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies. The test helps clinicians quickly identify heart attack and ...

Please provide your email address to receive an email when new articles are posted on . For this retrospective, observational, multicenter study, researchers assessed adult ED visits that included at ...

Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack. With this clearance, Roche is ...

Roche announced the primary results from the TSIX Study Programme, which evaluated the performance of its new sixth-generation high-sensitivity Troponin T test for diagnosing heart attacks. Presented ...